Evotec Other Assets vs Inventory Analysis
EVO Stock | USD 4.78 0.13 2.65% |
Evotec SE financial indicator trend analysis is much more than just examining Evotec SE ADR latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Evotec SE ADR is a good investment. Please check the relationship between Evotec SE Other Assets and its Inventory accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Other Assets vs Inventory
Other Assets vs Inventory Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Evotec SE ADR Other Assets account and Inventory. At this time, the significance of the direction appears to have pay attention.
The correlation between Evotec SE's Other Assets and Inventory is -0.75. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Inventory in the same time period over historical financial statements of Evotec SE ADR, assuming nothing else is changed. The correlation between historical values of Evotec SE's Other Assets and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Evotec SE ADR are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Other Assets i.e., Evotec SE's Other Assets and Inventory go up and down completely randomly.
Correlation Coefficient | -0.75 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Other Assets
Inventory
Most indicators from Evotec SE's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Evotec SE ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, Evotec SE's Selling General Administrative is very stable compared to the past year. As of the 9th of June 2024, Sales General And Administrative To Revenue is likely to grow to 0.26, while Tax Provision is likely to drop about 3.2 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 618.0M | 751.4M | 781.4M | 820.5M | Depreciation And Amortization | 67.6M | 81.7M | 99.9M | 104.9M |
Evotec SE fundamental ratios Correlations
Click cells to compare fundamentals
Evotec SE Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evotec SE fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Total Stockholder Equity | 477.0M | 722.8M | 1.4B | 1.2B | 1.1B | 1.2B | |
Common Stock Shares Outstanding | 151.5M | 154.9M | 167.1M | 176.7M | 176.9M | 188.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.5B | 2.2B | 2.3B | 2.3B | 2.4B | |
Other Stockholder Equity | 786.9M | 1.0B | 1.4B | 1.4B | 1.4B | 733.8M | |
Other Assets | 58.0M | 62.3M | 79.3M | 1.0 | 1.15 | 1.09 | |
Short Long Term Debt Total | 463.1M | 492.0M | 512.9M | 506.7M | 626.2M | 657.5M | |
Other Current Liab | 53.5M | 65.3M | 74.5M | 87.4M | 73.3M | 77.0M | |
Total Current Liabilities | 179.0M | 208.5M | 324.5M | 337.7M | 464.6M | 487.8M | |
Property Plant And Equipment Net | 239.2M | 337.3M | 484.6M | 650.2M | 806.6M | 846.9M | |
Net Debt | 186.1M | 69.8M | (186.4M) | 91.5M | 115.3M | 121.1M | |
Retained Earnings | (441.2M) | (434.2M) | (216.4M) | (392.4M) | (476.3M) | (500.1M) | |
Accounts Payable | 31.3M | 42.5M | 72.6M | 97.3M | 134.3M | 141.0M | |
Cash | 277.0M | 422.2M | 699.3M | 415.2M | 510.9M | 536.5M | |
Non Current Assets Total | 711.4M | 804.1M | 1.1B | 1.2B | 1.4B | 1.5B | |
Non Currrent Assets Other | 23.7M | 37.4M | 56.8M | 74.1M | 95.2M | 100.0M | |
Cash And Short Term Investments | 321.7M | 492.2M | 858.5M | 730.0M | 604.1M | 634.3M | |
Short Term Investments | 44.6M | 70.1M | 159.2M | 314.8M | 93.2M | 74.6M | |
Non Current Liabilities Total | 524.9M | 531.6M | 533.0M | 732.4M | 714.6M | 750.3M | |
Other Current Assets | 3.8M | 6.5M | 20.7M | 40.2M | 64.1M | 67.3M | |
Total Liab | 703.9M | 740.0M | 857.5M | 1.1B | 1.2B | 1.2B | |
Total Current Assets | 469.5M | 658.8M | 1.1B | 1.1B | 903.2M | 948.3M | |
Short Term Debt | 20.7M | 30.0M | 50.6M | 16.4M | 149.1M | 156.5M | |
Common Stock | 150.9M | 163.9M | 176.6M | 177.0M | 177.2M | 128.1M | |
Current Deferred Revenue | 73.4M | 70.6M | 126.8M | 136.7M | 107.9M | 113.2M | |
Net Receivables | 124.1M | 136.9M | 176.8M | 256.7M | 204.1M | 214.3M | |
Inventory | 10.7M | 13.6M | 25.8M | 29.8M | 30.9M | 32.4M | |
Good Will | 255.9M | 247.4M | 257.6M | 274.8M | 275.6M | 289.4M | |
Intangible Assets | 117.0M | 98.0M | 30.9M | 23.8M | 15.5M | 14.7M | |
Accumulated Other Comprehensive Income | (19.6M) | (37.5M) | (12.6M) | (37.4M) | (30.6M) | (32.2M) | |
Other Liab | 93.2M | 82.6M | 69.6M | 70.7M | 63.6M | 61.8M | |
Net Tangible Assets | 79.0M | 102.9M | 375.9M | 1.1B | 1.3B | 1.3B | |
Long Term Debt | 324.9M | 331.0M | 326.3M | 328.3M | 377.5M | 254.0M | |
Capital Lease Obligations | 131.9M | 145.6M | 150.4M | 176.8M | 203.3M | 112.1M | |
Net Invested Capital | 808.3M | 1.1B | 1.7B | 1.5B | 1.1B | 1.1B | |
Short Long Term Debt | 6.3M | 15.4M | 36.1M | 1.6M | 1.4M | 1.3M | |
Net Working Capital | 290.6M | 450.4M | 776.4M | 736.0M | 438.6M | 421.1M | |
Property Plant Equipment | 89.3M | 238.0M | 335.7M | 484.6M | 557.3M | 585.2M | |
Long Term Investments | 41.3M | 59.0M | 287.0M | 150.3M | 142.1M | 129.9M | |
Capital Stock | 150.9M | 163.9M | 176.6M | 177.0M | 177.2M | 182.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Evotec Stock
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 2.194 | Quarterly Revenue Growth (0.02) | Return On Assets 0.0003 | Return On Equity (0.08) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.